Innovative Treatments for Childhood Asthma


The statistics are staggering: More than 6 million American children suffer from asthma. Additionally, 14 million days of school missed each year due to asthma-related issues, making the disease the most burdensome chronic condition facing American children. For years, caregivers have faced serious challenges with traditional inhaler treatments: it’s hard for little ones to comply, air masks leak and nebulizers keep them awake. Join us as Tonya Winders, President and CEO of The Allergy and Asthma Network, offers her expertise and support to parents of asthmatics. Inspired by the treatment challenges faced by millions of young asthma sufferers and their caregivers, Lupin Pharmaceuticals, working with InspiRx, has developed two groundbreaking new treatments: InspiraChamber® and SootherMask®.